Literature DB >> 18393745

Management of adrenal insufficiency during the stress of medical illness and surgery.

Caroline Jung1, Warrick J Inder.   

Abstract

Patients with adrenal insufficiency (AI) require additional glucocorticoid doses during surgery or medical illness, but there is no universally accepted regimen for glucocorticoid supplementation therapy. The high doses and long duration of glucocorticoid coverage that have traditionally been used do not reflect the hypothalamic-pituitary-adrenal response to surgical stress and medical illness in normal people. While the optimal dose and duration of supplementation therapy have not been established, our recommendations are based on extrapolation from what constitutes a normal cortisol response to stress, on expert opinion derived from the medical literature, and on clinical experience. The recommended use of lower doses of glucocorticoids during surgical and medical stress should not de-emphasise the importance of additional supplementation during such events. Our recommendations do not replace clinical judgement, but their use will ensure that patients with AI are safely managed during illness or surgery without the risk of an adrenal crisis or excessive steroid dosing.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18393745     DOI: 10.5694/j.1326-5377.2008.tb01686.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  6 in total

Review 1.  Stress Dose Steroids: Myths and Perioperative Medicine.

Authors:  C Ronald MacKenzie; Susan M Goodman
Journal:  Curr Rheumatol Rep       Date:  2016-07       Impact factor: 4.592

2.  Dispensing patterns of emergency medicines prescribed by Australian dentists from 1992 to 2018 - a pharmacoepidemiology study.

Authors:  Joon Soo Park; Estie Kruger; Marc Tennant
Journal:  Int Dent J       Date:  2020-03-13       Impact factor: 2.607

3.  Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers.

Authors:  Caroline Jung; Santo Greco; Hanh H T Nguyen; Jui T Ho; John G Lewis; David J Torpy; Warrick J Inder
Journal:  BMC Endocr Disord       Date:  2014-11-26       Impact factor: 2.763

4.  Impact and indication of early systemic corticosteroids for very severe community-acquired pneumonia.

Authors:  Motoi Ugajin; Kenichi Yamaki; Natsuko Hirasawa; Takanori Kobayashi; Takeo Yagi
Journal:  Int J Gen Med       Date:  2013-08-20

Review 5.  COVID-19 and the use of immunomodulatory and biologic agents for severe cutaneous disease: An Australian/New Zealand consensus statement.

Authors:  Charlie Wang; Marius Rademaker; Christopher Baker; Peter Foley
Journal:  Australas J Dermatol       Date:  2020-05-03       Impact factor: 2.481

6.  Empiric Stress Dose Steroids in Trauma Patients: A Case Report of Hypopituitarism in Traumatic Hemorrhage.

Authors:  Marissa Haberlach; Cy Cedar; Andrew McCague
Journal:  J Emerg Trauma Shock       Date:  2019 Jan-Mar
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.